Biohaven (BHVN) Capital Expenditures (2021 - 2025)
Biohaven (BHVN) reported Capital Expenditures of $8000.0 for Q4 2025, down 83.67% on a YoY basis from $49000.0 in Q4 2024, and down 38.46% sequentially from $13000.0 in Q3 2025.
Biohaven (BHVN) Capital Expenditures (2021 - 2025) Analysis & Trends
Biohaven (BHVN) has 5 years of Capital Expenditures data on file, last reported at $8000.0 in Q4 2025.
- For the quarter ending Q4 2025, Capital Expenditures fell 83.67% year-over-year to $8000.0; the trailing twelve-month figure through Mar 2026 stood at $254000.0 (down 93.76% YoY), and the FY2025 full-year result was $715000.0, down 82.34% from the prior year.
- Capital Expenditures eased to $8000.0 in Q4 2025, from $13000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $4.5 million in Q3 2022 to a low of $8000.0 in Q4 2025.
- A 5-year average of $863823.5 and a median of $470000.0 in 2023 frame the typical range for Capital Expenditures.
- Across the five-year window, Capital Expenditures soared 395.63% in 2024 and slumped 97.87% in 2025, its largest moves.
- Tracing BHVN's Capital Expenditures over 5 years: stood at $799000.0 in 2021, then slumped by 62.45% to $300000.0 in 2022, then jumped by 56.67% to $470000.0 in 2023, then sank by 89.57% to $49000.0 in 2024, then slumped by 83.67% to $8000.0 in 2025.
- Business Quant data shows BHVN's Capital Expenditures at $8000.0 in Q4 2025, $13000.0 in Q3 2025, and $233000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | Biohaven | 2.16 Bn | 1.81 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 8,000.00 |
| Dec 31, 2025 | 8,000.00 |
| Sep 30, 2025 | 13,000.00 |
| Sep 30, 2025 | 13,000.00 |
| Jun 30, 2025 | 233,000.00 |
| Jun 30, 2025 | 233,000.00 |
| Mar 31, 2025 | 461,000.00 |
| Mar 31, 2025 | 461,000.00 |
| Dec 31, 2024 | 49,000.00 |
| Dec 31, 2024 | 49,000.00 |
| Sep 30, 2024 | 611,000.00 |
| Sep 30, 2024 | 611,000.00 |
| Jun 30, 2024 | 2.95 Mn |
| Jun 30, 2024 | 2.95 Mn |
| Mar 31, 2024 | 440,000.00 |
| Mar 31, 2024 | 440,000.00 |
| Dec 31, 2023 | 470,000.00 |
| Dec 31, 2023 | 470,000.00 |
| Sep 30, 2023 | 1.25 Mn |
| Sep 30, 2023 | 1.25 Mn |